In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Health Care Select Sector SPDR Fund

The U.S. government shut down on Oct. 1, 2025, as last-minute talks failed. ETFs like TLT, XLV and PSCC hog attention.

US Government Shutdown Puts These ETFs in Focus

With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum.

Boost Your Portfolio With These Top-Ranked ETFs

Call writing closed-end funds can offer attractive monthly distributions, along with the opportunity to trade at discounts to their historical net asset values. That discount can create an opportunity for investors to enter at attractive prices while getting the underlying portfolio on 'sale.' Today, we are looking at two CEFs that provide monthly distributions and are presenting relatively attractive discounts.

2 Call Writing Funds Providing Monthly Distributions For Passive Income

Healthcare sector trades at a historic discount due to patent expirations, managed care uncertainty, and drug pricing proposals, but pessimism is overdone. Key catalysts include potential M&A activity and likely continued NIH funding, both of which could drive sector recovery and rerating. XLV stands out among healthcare ETFs for its liquidity, high concentration in undervalued leaders, low turnover, and minimal fees.

XLV: Market Overreaction Could Drive Double Digit Shareholder Yield

August jobs data show healthcare gains lifting XLV, while manufacturing weakness drags on XLI.

Downbeat August Jobs Data Puts Focus on These Sector ETFs

The healthcare sector, represented by the Health Care Select Sector SPDR Fund NYSEARCA: XLV, has significantly lagged behind the broader market in 2025. Year-to-date, XLV is down about 1%, while the S&P 500 has continued to show resilience and storm higher toward new all-time highs.

Is Healthcare Setting Up to Be a Quiet Leader Into Year-End?

Brooke May, Evans May Wealth managing partner, joins 'Closing Bell Overtime' to talk what sectors she is keeping an eye on in this market.

Health care sector is resilient, 'won't stay down forever', says Evan May Wealth's Brooke Evans

XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.

Is This the Right Time to Consider Healthcare ETFs?

Lisa Gill, JP Morgan healthcare analyst, on “Worldwide Exchange,” says healthcare is at an inflection point, with UnitedHealth poised for long-term gains as big investors bet on a turnaround.

Gill: We're at a real inflection point for healthcare

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on December 16, 1998.

Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?

The Investment Committee give you their top stocks to watch for the second half.

Final Trades: Netflix, Wynn Resorts, Buckle and the XLV

Healthcare led July job gains with 55,000 new positions, as most other U.S. sectors showed little to no growth. Tap ETFs like XLV and VHT.

Healthcare: Winning Sector ETF Amid Soft U.S. July Jobs Report

Investing in healthcare has long been a cornerstone of defensive, long-term growth strategies. It is, after all, a massive and expanding segment of the global economy.

Beyond Broad Healthcare: A Smarter Prescription for Growth

Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.

Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector

Jared Holz, Mizuho health care sector strategist, joins 'The Exchange' to discuss the pain in the health care sector and if there are any opportunity plays within.

Managed care needs to improve to improve health care sector, says Mizuho's Jared Holz

'The Big Money Show' panel discusses President Donald Trump's pharmaceutical tariff strategy.

Trump's deadline looms for Big Pharma companies facing new tariffs

The life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients for longer periods. Investors pay low fees to hold XLV, since the expense ratio of this financial instrument is only 0.08%. For this year, the top ten holdings of XLV expect a median revenue growth rate of 7.3% and a median EBITDA growth rate of 33.82%.

XLV: Life Expectancy, Patents, And A Positive Outlook Will Pave The Way

Today's market reminds us of 1999 in many ways. REITs were hated. Tech was loved. But afterward, REITs strongly outperformed. Here's why it could happen again.

A Historic Opportunity For REIT Investors

Rick Ducat turns to the healthcare sector on today's options analysis. He starts with the SPDR Health Care ETF (XLV), noting the recent breakdown of a head and shoulders pattern and potential for both bearish and bullish action ahead.

Measuring Options Activity in MRK & XLV: Healthcare Levels to Watch

Real-time stock quote and overview for XLV